Here is yet another example of one of the nation s largest brands responding to pressure from American consumers and activist groups. Subway has chosen to remove the chemical
Even we at ACSH were surprised at this one. The discussion about the reasons behind the
Should they be called fractavists or frackophobes? Ah, what s in a name? The simple fact is, no matter how loudly they wail about fracking-related groundwater contamination, there is no there, there. Even Obama appointees agree.
Who can consumers trust for information on health and nutrition? It seems that the news media is not in the running at least that s the indication of a new study by the Center for Media and Public Affairs (CMPA) at George Mason University.
According to Dr. Mark Grabowsky, of the Office of the (UN) Secretary General s Special Envoy, referring to the dramatic reduction in contagious diseases over the past century, The elimination of the diseases from the Americas is a triumph of public health. And how do we explain that triumph? It s
Plasticizer chemicals phthalates by name again found to be safe for infants and toddlers in toys. Also safe in sex toys, so that covers the entire age range, it would seem.
In his recent piece, which appeared in The New Hampshire Union Leader, Deroy Murdock hits all the right notes with a very convincing argument on why everyone regardless, or even despite their political leanings - should think very carefully about the benefits the US could derive from tapping its natural gas supplies as well as about the overstated risks.
According to the USDA, about 23.5 million Americans live in areas known as food deserts areas lacking access to fresh fruits and
CVS Caremark, the national pharmacy chain, announced that it will eliminate sales of tobacco products over the next year. The announcement was met with approval by Drs Schroeder and Brennan (from CVS Caremark and the
10 drug companies that normally compete against each other, including giants Sanofi and Pfizer, will now cooperate not just with government researchers and non-profits, but with each other as part of a five-year, $230 million partnership to speed up the pace of new drug development in several key conditions Alzheimer's disease, type 2 diabetes, rheumatoid arthritis and lupus according to an announcement from the National Institutes of Health.
